TG Therapeutics | TGTX - Ativo Circulante

Preço das Ações
33.72
Mudança Diária
-0.06 -0.18%
Mensal
0.57%
Anual
-22.38%
Q2 Previsão
35.84




Ativo Circulante Alterar Data
AbbVie USD 29.06B 523M 2025-12
Alaunos Therapeutics USD 1.99M 697K 2025-12
Amgen USD 31.48B 2.42B 2026-03
Ardelyx USD 381.87M 447K 2026-03
Arrowhead Research USD 1.17B 223.75M 2025-12
Bayer EUR 32.91B 30M 2025-12
Biogen USD 9.19B 216.3M 2026-03
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Curis USD 6.92M 7.5M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
J&J USD 59.17B 3.55B 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novavax USD 978.28M 3.69M 2025-12
PTC Therapeutics USD 2.27B 266.14M 2025-12
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
TG Therapeutics USD 630.76M 31M 2025-12
Verastem USD 223.41M 69.36M 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12